Kinetics of factor VIII-von Willebrand factor association

Blood

Volumn 87, Issue 5, 1996, Pages 1809-1816

  Vlot, André J ^a   Koppelman, Stefan J ^b   Meijers, Joost C M ^b   Damas, Conchi ^b   Van Den Berg, H Marijke ^b   Bouma, Bonno N ^b   Sixma, Jan J ^b   Willems, George M ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; EPITOPE; MONOCLONAL ANTIBODY; RECOMBINANT VON WILLEBRAND FACTOR; SEPHAROSE; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

ARTICLE; ASSOCIATION; BINDING COMPETITION; BINDING KINETICS; BINDING SITE; CENTRIFUGATION; COMPLEX FORMATION; CONTROLLED STUDY; DISSOCIATION CONSTANT; HEMOPHILIA A; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL;

EID: 0029966328     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.5.1809.bloodjournal8751809     Document Type: Article

References (36)

1. Hoyer LW: The factor VIII complex: Structure and function. Blood 58:1, 1981
2. Wion KL, Kelly D, Summerfield JA, Tuddenham EG, Lawn RM: Distribution of factor VIII mRNA and antigen in human liver and other tissues. Nature 317:726, 1985
3. Fay PJ: Factor VIII structure and function Thromb Haemost 70:63, 1993
4. Weiss HJ, Baumgartner HR, Tschopp TB, Turitto VT, Cohen D: Correction by factor VIII of the impaired platelet adhesion to subendothelium in von Willebrand disease. Blood 51:267, 1978
5. Sakariassen KS, Bolhuis, PA, Sixma JJ. Human blood platelet adhesion to artery subendothelium is mediated by factor VIII-von Willebrand factor bound to the subendothelium. Nature 279:636, 1979
6. Sadler JE: von Willebrand factor. J Biol Chem 266:22777, 1991
7. Jaffe EA, Hoyer LW, Nachman R: Synthesis of antihemophilic factor antigen by human endothehal cells. J Clin Invest 52:2757, 1973
8. Wagner DD, Marder VJ: Biosynthesis of von Willebrand protein by human endothelial cells. J Biol Chem 258:2065, 1983
9. Nachman R, Levine R, Jaffe EA: Synthesis of factor VIII antigen by cultured guinea pig megakaryocytes. J Clin Invest 60:914, 1977
10. Over J, Sixma JJ, Bruine MH, Trieschnigg MC, Vlooswijk RA, Beeser-Visser NH, Bouma BN: Survival of 125iocline-labeled factor VIII in normals and patients with classic hemophilia. Observations on the heterogeneity of human factor VIII. J Clin Invest 62:223, 1978
11. Weiss HJ, Sussman II, Hoyer LW. Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand's disease. J Clin Invest 60:390, 1977
12. Sadler JE: A revised classification of von Willebrand disease. Thromb Haemost 71:520, 1994
13. Nishino M, Girma JP, Rothschild C, Fressinaud E, Meyer D: New variant of von Willebrand disease with defective binding to factor VIII. Blood 74:1591, 1989
14. Koedam JA, Meijers JC, Sixma JJ, Bouma BN: Inactivation of human factor VIII by activated protein C. Cofactor activity of protein S and protective effect of von Willebrand factor. J Clin Invest 82:1236, 1988
15. Koedam JA, Hamer RJ, Beeser-Visser NH, Bouma BN, Sixma JJ: The effect of von Willebrand factor on activation of factor VIII by factor Xa. Eur J Biochem 189:229, 1990
16. Koppelman SJ, Koedam JA, van Wijnen M, Stern D, Nawroth P, Sixma JJ, Bouma BN: Von Willebrand factor as a regulator of intrinsic factor X activation J Lab Clin Med 123:585, 1994
17. Hamer RJ, Koedam JA, Beeser-Visser NH, Bertina RM, van Mourik JA, Sixma JJ: Factor VIII binds to von Willebrand factor via its Mr-80,000 light chain. Eur J Biochem 166:37, 1987
18. Leyte A, Verbeet MP, Brodniewicz-Proba T, van Mourik JA, Mertens K: The interaction between human blood-coagulation factor VIII and von Willebrand factor. Characterization of a high-affinity binding site on factor VIII. Biochem J 257:679, 1989
19. Nesheim M, Pittman DD, Giles AR, Fass DN, Wang JH, Slonosky D, Kaufman RJ: The effect of plasma von Willebrand factor on the binding of human factor VIII to thrombin-activated human platelets. J Biol Chem 266:17815, 1991
20. Lollar P, Parker CG: Stoichiometry of the porcine factor VIII-von Willebrand factor association. J Biol Chem 262:17572, 1987
21. Vlot AJ, Koppelman SJ, van den Berg HM, Bouma BN, Sixma JJ: The affinity and Stoichiometry of binding of human factor VIII to von Willebrand factor. Blood 85:3150, 1995
22. Palmiter RD, Behringer RR, Quaife CJ, Maxwell F, Maxwell IH, Brinster RL: Cell lineage ablation in transgenic mice by cell-specific expression of a toxin gene. Cell 50:435, 1987
23. Lawrie AS, Hoser MJ, Savidge GF: Phast assessment of vWf:Ag multimeric distribution. Thromb Res 59:369, 1990
24. Tripodi A, Mannucci PM: Factor VIII activity as measured by an amidolytic assay compared with a one-stage clotting assay Am J Clin Pathol 86:341, 1986
25. Lopez-Fernandez MF, Blanco-Lopez MJ, Castineira MP, Batlle J: Further evidence for recessive inheritance of von Willebrand disease with abnormal binding of von Willebrand factor to factor VIII. Am J Hematol 40:20, 1992
26. Layet S, Girma JP, Obert B, Peynaud-Debayle E, Bihoreau N, Meyer D: Evidence that a secondary binding and protecting site for factor VIII on von Willebrand factor is highly unlikely. Biochem J 282:129, 1992
27. Over J, Bouma BN, Sixma JJ, Bolhuis PA, Vlooswijk RA: Heterogeneity of human factor VIII. III. Transitions between forms of factor VIII present in cryoprecipitate and in cryosupernatant plasma. J Lab Clin Med 95:323, 1980
28. Zelechowska MG, van Mourik JA, Brodniewicz-Proba T: Ultrastructural localization of factor VIII procoagulant antigen in human liver hepatocytes. Nature 317:729, 1985
29. Horn T, Lyon H, Christoffersen P: The blood hepatocytic barrier: A light microscopical, transmission- and scanning electron microscopic study. Liver 6:233, 1986
30. Wisse E: An electron microscopic study of the fenestrated endothelial lining of rat liver sinusoids J Ultrastruct Res 31:125, 1970
31. Kasper CK, Kim HC, Gomperts ED, Smith KJ, Salzman PM, Tipping D, Miller R, Montgomery RM: In vivo recovery and survival of monoclonal-antibody-purified factor VIII concentrates. Thromb Haemost 66:730, 1991
32. Lusher JM, Arkin S, Abildgaard CF, Schwartz RS, Kogenate Previously Untreated Patient Study Group: Recombinant factor VIII for the treatment of previously untreated patients with hemophilia A. Safety, efficacy, and development of inhibitors. N Engl J Med 328:453, 1993
33. Brinkhous KM, Sandberg H, Garris JB, Mattsson C, Palm M, Griggs T, Read MS: Purified human factor VIII procoagulant protein: Comparative hemostatic response after infusions into hemophilic and von Willebrand disease dogs. Proc Natl Acad Sci USA 82:8752, 1985
34. Wise RJ, Domer AJ, Krane M, Pittman DD, Kaufman RJ: The role of von Willebrand factor multimers and propeptide cleavage in binding and stabilization of factor VIII. J Biol Chem 266:21948, 1991
35. Lenting PJ, Donath MJ, van Mourik JA, Mertens K: Identification of a binding site for blood coagulation factor IXa on the light chain of human factor VIII. J Biol Chem 269:7150, 1994
36. Gilbert GE, Furie BC, Furie B: Binding of human factor VIII to phospholipid vesicles. J Biol Chem 265:815, 1990